GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Biosig Technologies
Biosig is a company that produces a medical device for reducing noise during ECG recordings, particularly during arrhythmia treatment procedures. Its stock price reflects the slow adoption of this innovative technology in cardiology practice.
Share prices of companies in the market segment - Therapeutic medical equipment
Biosig Technologies is developing the innovative PURE EP system, which helps electrophysiologists obtain clearer cardiac signals during arrhythmia treatments. We've categorized it as "Therapeutic Medical Equipment." The graph below shows the dynamics in the high-tech cardiology sector.
Broad Market Index - GURU.Markets
BioSig Technologies has developed a cutting-edge system for obtaining clear cardiac signals during cardiac procedures. Its innovative technology makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how BioSig compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
BSGM - Daily change in the company's share price Biosig Technologies
Biosig Technologies, Inc.'s daily price change reflects volatility in the medical equipment sector. The metric shows sensitivity to sales of its cardiac procedure system, providing an indication of market conditions.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Biosig Technologies has developed a cutting-edge system for obtaining clear cardiac signals during arrhythmia treatment procedures. The cardiology medical equipment market is highly technological. The chart below shows the volatility in this sector, allowing one to assess how the market is embracing BSGM's innovations.
Daily change in the price of a broad market stock, index - GURU.Markets
Biosig Technologies has developed technology for more accurate ECG readings. Shares of this innovative medical technology company are responding to clinical advances and regulatory decisions, contributing to the overall volatility in the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Biosig Technologies
Biosig Technologies' year-over-year performance is a story of commercialization of its arrhythmia treatment navigation system. Its 12-month market cap reflects its success in deploying its PURE EP platform in cardiac centers, a fundamental step in validating the clinical and economic value of its technology.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Biosig Technologies, Inc. is a medical device company that has developed a cutting-edge system for visualizing cardiac signals during arrhythmia treatment. This chart shows how its innovative, yet niche, technology and its efforts to expand its use in hospitals are impacting its performance in the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Biosig Technologies, a company developing a system to improve cardiac signal visualization during arrhythmia treatment, aims to improve the precision of cardiac surgery. Its annual market capitalization growth reflects the success of its technology in leading clinics.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Biosig Technologies
Biosig is a medical device company that has developed a system for reducing noise in ECG recordings. Its monthly growth reflects progress in commercializing its technology. News of its system's implementation in leading hospitals is a key driver.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Biosig Technologies has developed a cutting-edge system for visualizing cardiac signals during arrhythmia treatments. This medical equipment sector aims to improve the precision and safety of complex cardiac procedures. The chart below shows how investors assessed the prospects for innovative technologies in electrophysiology.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Biosig Technologies develops technology to enhance the clarity of biosignals, for example, in cardiology. It's a medical technology company. Its stock price depends on the adoption of its system by hospitals and surgeons, a slow but potentially highly profitable process.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Biosig Technologies
Shares of Biosig Technologies, which develops systems for cardiac procedures, reflect progress in this area of MedTech. Weekly price movements depend on news about the implementation of their technology in clinics and clinical data reports. The chart below shows how short-term developments in the medical technology sector influence the company's valuation.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
BioSig Technologies is developing a technology to improve the diagnosis and treatment of arrhythmia, a major medical problem. The chart below shows how progress in commercializing its product is impacting its stock price, setting it apart from other medical device giants.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Biosig Technologies is a medical technology startup. This chart compares its weekly volatility with the market. It shows how its stock, like other early-stage companies, is driven by news about the adoption of its technology rather than by overall market trends.
Market capitalization of the company, segment and market as a whole
BSGM - Market capitalization of the company Biosig Technologies
Biosig Technologies, Inc.'s valuation reflects its years-long efforts to commercialize its system for more accurate visualization of cardiac signals during arrhythmia treatment procedures. The company's market cap demonstrates the difficulty of a medical tech startup achieving widespread acceptance in the medical community.
BSGM - Share of the company's market capitalization Biosig Technologies within the market segment - Therapeutic medical equipment
Biosig Technologies' market share in the therapeutic equipment sector reflects its innovations in cardiac electrophysiology. Its market share is driven by the acclaim of its PURE EP system, which helps physicians obtain clearer signals from the heart during arrhythmia treatments, improving their accuracy.
Market capitalization of the market segment - Therapeutic medical equipment
The chart below is a barometer of the cardiac electrophysiology medical equipment market. BioSig Technologies is one of the innovators in this niche. The dynamics in the chart reflect how the market values technologies that help doctors obtain a cleaner signal when treating arrhythmias.
Market capitalization of all companies included in a broad market index - GURU.Markets
This graph depicts the market value of technology that helps "hear" the heart. Biosig Technologies' market capitalization is the valuation of its system for more accurate diagnosis and treatment of arrhythmia. The line shows how innovations in cardiology are competing for share in the global medical equipment industry.
Book value capitalization of the company, segment and market as a whole
BSGM - Book value capitalization of the company Biosig Technologies
This chart illustrates the technological foundation of Biosig Technologies. Its assets include patents and the PURE EP™ system for accurately reading cardiac signals during arrhythmia treatment procedures. The chart's dynamics show how the company is investing in the development and commercialization of its unique medical technology.
BSGM - Share of the company's book capitalization Biosig Technologies within the market segment - Therapeutic medical equipment
Biosig Technologies' tangible assets include its R&D centers for developing its cardiac signal mapping system. The chart shows the company's stake in this high-tech medical infrastructure, which is designed to improve the accuracy of arrhythmia treatment procedures.
Market segment balance sheet capitalization - Therapeutic medical equipment
In the capital-intensive world of medical equipment, Biosig Technologies operates at the cutting edge of technology. Its business requires manufacturing capacity to create its unique cardiology systems, making its model moderately capital-intensive.
Book value of all companies included in the broad market index - GURU.Markets
BioSig Technologies is developing a cutting-edge system for visualizing cardiac signals during arrhythmia treatments. The company's assets are not hospitals, but rather the technology and manufacturing facilities needed to create these high-definition "cardiac screens." The graph below shows the impact of this innovation in cardiology.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Biosig Technologies
BioSig Technologies is developing a cutting-edge system for visualizing cardiac signals during cardiac procedures. Its value lies in this unique technology. The chart below shows how the market perceives its commercial potential and the speed of its adoption at leading cardiac centers.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Biosig Technologies, Inc. is developing a system to reduce noise and improve signal quality in cardiac electrophysiology. Its value lies in this unique technology. This chart shows how its market valuation, reflecting its product's potential, relates to its tangible assets.
Market to book capitalization ratio for the market as a whole
Biosig Technologies is developing a technology to improve cardiac signal visualization during arrhythmia treatment procedures. This chart shows how the market is assessing their unique PURE EP system and its potential to become a standard in electrophysiology.
Debts of the company, segment and market as a whole
BSGM - Company debts Biosig Technologies
BioSig Technologies, a company developing biosignal processing systems, is using raised capital to commercialize its first product for cardiologists. This chart shows how the company is investing in its sales and marketing to convince hospitals to adopt its innovative technology.
Market segment debts - Therapeutic medical equipment
BioSig Technologies is developing an innovative cardiac signal processing system that assists physicians during arrhythmia treatment procedures. This chart illustrates how its leverage reflects the long and arduous road to commercializing this complex medical technology, requiring significant investment in clinical data and sales.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Biosig Technologies
BrightSphere Investment Group is a holding company with stakes in various asset management firms. This chart shows its corporate financial structure. Debt can be used for acquisitions or to return capital to shareholders, reflecting its strategy as a financial holding company.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
BioSig Technologies develops an advanced signal processing system for cardiology, which helps improve the diagnosis and treatment of arrhythmias. This chart compares its debt to the overall market capitalization of the entire sector. It shows how the medical device company finances its innovative technologies.
Debt to book value of all companies in the market
BioSig Technologies is developing a cutting-edge system for processing cardiac signals during arrhythmia treatments. Introducing new equipment to cardiology is a complex task. This graph of total market debt helps understand the financial environment in which BioSig is raising capital to commercialize its technology and train electrophysiologists.
P/E of the company, segment and market as a whole
P/E - Biosig Technologies
This chart for Biosig Technologies, a medical device company developing cardiology systems, reflects expectations for its technology. The price-to-earnings ratio (if any) will be based on investors' belief that its device, which improves procedural accuracy, will become a standard in electrophysiology labs.
P/E of the market segment - Therapeutic medical equipment
Biosig Technologies has developed an innovative cardiac electrophysiology system that enables clearer and more accurate signals during arrhythmia treatment procedures. This chart shows the average rating for the therapeutic equipment sector, reflecting how the market values technologies that improve the precision and safety of complex medical procedures.
P/E of the market as a whole
BioSig Technologies develops an advanced signal processing system for electrophysiology, which helps cardiologists obtain clearer signals from the heart during arrhythmia treatments. This risk appetite chart helps understand how investors value innovative medical device companies.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Biosig Technologies
BioSig Technologies is developing a cutting-edge electrophysiology signal processing system that helps doctors more accurately perform arrhythmia procedures. This graph reflects future revenue expectations based on the adoption of its technology in hospitals.
%20P%2FE%20Biosig%20Technologies&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Biosig-Technologies&v=1772630149926 "Chart of the company's future (projected) P/E Biosig Technologies")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Biosig Technologies is developing an advanced electrocardiogram recording and analysis system for use in electrophysiology procedures. This chart reflects how the market is assessing its technology, comparing expectations for Biosig with those of other medical equipment manufacturers.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772630149975 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Biosig Technologies is developing an innovative system for reducing noise and artifacts in ECG and other biosignal recordings. The implementation of their PURE EP technology depends on acceptance by the medical community. The overall economic backdrop, visible in this graph, influences hospital budgets and their willingness to invest in new equipment to improve diagnostics.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772630149998 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Biosig Technologies
BioSig Technologies develops and commercializes technology to improve electrophysiological procedures for the treatment of arrhythmia. Its financial results depend on sales of its PURE EP system to hospitals. This chart shows the company's path to introducing a new medical technology to a conservative market and achieving commercial success.
Profit of companies in the market segment - Therapeutic medical equipment
Biosig Technologies is developing innovative PURE EP™ technology to obtain clearer signals during cardiac arrhythmia treatments. This graph, showing overall sector profitability, reflects the drive to improve precision in medicine. The success of Biosig's technology has the potential to improve patient outcomes and impact standards across cardiology.
Overall market profit
Biosig Technologies has developed a cutting-edge cardiology system that helps doctors obtain clearer signals from the heart during arrhythmia treatments. Its technology is aimed at improving the precision and safety of complex medical interventions.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Biosig Technologies
Biosig Technologies is developing a cutting-edge system for visualizing cardiac signals during electrophysiological procedures. Future revenue projections depend on the implementation of their PURE EP™ technology in hospitals and cardiology centers.
%20profit%20of%20the%20company%20Biosig%20Technologies&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Biosig-Technologies&v=1772630150149 "Graph of future (projected) profit of the company Biosig Technologies")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Biosig Technologies develops an advanced signal processing system to reduce noise and artifacts in electrocardiograms used in electrophysiology. This chart shows revenue forecasts for the therapeutic medical equipment sector. It helps assess how the company's technology, which improves procedural accuracy, compares to overall trends in cardiology.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772630150157 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
Biosig Technologies is developing an innovative system for more accurate visualization of cardiac signals during arrhythmia treatment. The implementation of such technologies depends on hospital budgets. This graph, reflecting the state of the economy, affects Biosig, as during periods of growth, medical institutions invest more actively in advanced equipment.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772630150162 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Biosig Technologies
BioSig Technologies develops an advanced electrophysiology signal processing system that helps doctors treat cardiac arrhythmia. This metric, which compares market capitalization to initial revenue, reflects its commercialization efforts. It demonstrates how investors view its technology and its potential to become a standard in electrophysiology laboratories.
P/S market segment - Therapeutic medical equipment
BioSig Technologies develops and commercializes the advanced PURE EP™ signal processing system, which helps electrophysiologists obtain clearer cardiac signals during arrhythmia treatment procedures. This chart reflects the market's willingness to pay for revenue in the medical technology sector, demonstrating confidence in the innovation and clinical value of BioSig's system.
P/S of the market as a whole
BioSig Technologies is developing the PURE EP biomedical signal processing platform, which aims to improve the diagnosis and treatment of cardiac arrhythmias. This chart shows how the market values companies developing advanced electrophysiology technologies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Biosig Technologies
BioSig Technologies is developing an advanced signal processing system for cardiac electrophysiology. This chart shows how investors value the company based on its projected future sales. It reflects the belief that its technology will improve the precision of arrhythmia treatment procedures.
%20P%2FS%20Biosig%20Technologies&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Biosig-Technologies&v=1772630150287 "The graph of the company's future (projected) P/S Biosig Technologies")
Future (projected) P/S of the market segment - Therapeutic medical equipment
BioSig Technologies is developing the PURE EP platform to minimize noise and artifacts in cardiac electrophysiological signals. The chart shows the average estimated future revenue for therapeutic device manufacturers. It helps understand the market's perception of BioSig's technology's potential to improve arrhythmia treatment outcomes and its commercial prospects.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772630150337 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
Biosig Technologies (BSGM) is developing an innovative system to improve the precision of cardiac arrhythmia treatment procedures. Their growth depends on the adoption of their technology in cardiology centers. This figure is important because economic growth allows clinics to invest in new equipment, but the main driver is clinical effectiveness.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772630150379 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Biosig Technologies
Biosig Technologies' revenue is generated by sales of its innovative cardiology system. The company sells the PURE EP device, which helps electrophysiologists obtain clearer cardiac signals during arrhythmia treatment procedures. This growth reflects the adoption of its technology in leading cardiology centers.
Sales of companies in the market segment - Therapeutic medical equipment
BioSig Technologies has developed the PURE EP system to improve signal quality during cardiac arrhythmia treatment procedures. As its commercialization progresses, its revenue structure will reflect the proportion of sales of the system itself versus disposable consumables.
Overall market sales
BioSig Technologies, Inc. is developing an advanced signal processing system for cardiology that helps improve arrhythmia diagnostics. Demand for its technology depends on hospital budgets and their commitment to innovation. This trend, reflecting the overall economic situation, affects the healthcare system's ability to invest in new equipment to improve treatment outcomes.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Biosig Technologies
BioSig Technologies is developing an advanced electrophysiology signal processing system that helps doctors treat cardiac arrhythmias. This graph reflects analysts' expectations for the implementation of its PURE EP technology in hospitals.
%20sales%20of%20the%20company%20Biosig%20Technologies&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Biosig-Technologies&v=1772630150426 "Schedule of future (projected) sales of the company Biosig Technologies")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
BioSig Technologies is developing the advanced PURE EP signal processing system for cardiac electrophysiology research. This graph shows the outlook for the therapeutic medical device sector, reflecting the need for more accurate data for the diagnosis and treatment of cardiac arrhythmias.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772630150483 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
This chart illustrating healthcare costs is important to Biosig Technologies. The company develops systems for precise visualization of cardiac signals during procedures. Demand for its equipment depends on hospital budgets and their desire to implement advanced technologies to improve treatment outcomes.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772630150534 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Biosig Technologies
BioSig Technologies is developing an advanced signal processing system to improve cardiac arrhythmia treatment. This chart shows financial results at the commercialization stage. Profitability depends on the successful implementation of its technology in hospital electrophysiology labs worldwide.
Market segment marginality - Therapeutic medical equipment
BioSig Technologies develops an advanced signal processing system for electrophysiology, which helps doctors obtain clearer cardiac signals during arrhythmia treatments. Profitability depends on the adoption of its technology in hospitals. This chart shows the average profitability in the sector, allowing one to assess its innovative potential.
Market marginality as a whole
Biosig Technologies is developing an innovative system for visualizing cardiac signals during cardiac procedures. Demand for its technology depends on its adoption by leading clinics. This trend, reflecting the state of the economy, impacts hospital budgets, which determine their ability to purchase new, advanced medical equipment to improve treatment outcomes.
Employees in the company, segment and market as a whole
Number of employees in the company Biosig Technologies
BioSig Technologies is developing a cutting-edge signal processing system for cardiac electrophysiology. This graph depicts the team's engineering and sales team. The progression shows the company's efforts to commercialize its technology and implement it in hospitals to improve the accuracy of arrhythmia treatments.
Share of the company's employees Biosig Technologies within the market segment - Therapeutic medical equipment
BioSig Technologies developed the PURE EP system to improve signal quality during cardiac electrophysiology procedures. This chart shows the company's share of the total number of engineers in the cardiology medical equipment niche. This reflects its unique technology and its efforts to implement it in clinical practice.
Number of employees in the market segment - Therapeutic medical equipment
BioSig Technologies, Inc. is developing the PURE EP™ medical device, which improves signal quality in the treatment of cardiac arrhythmias. This chart, showing employment in the therapeutic medical device sector, is important. The growing number of engineers and electrophysiologists working on new technologies demonstrates the desire to improve the precision and safety of cardiac procedures.
Number of employees in the market as a whole
Biosig Technologies develops advanced systems for visualizing cardiac signals during arrhythmia treatment. This overall occupancy chart reflects the financial health of hospitals. A stable economy provides funding that allows cardiology centers to invest in the latest technologies that improve the precision and safety of complex procedures.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Biosig Technologies (BSGM)
Biosig Technologies (BSGM) is a medical equipment company, specifically the PURE EP system for accurately recording ECG readings during cardiac procedures. This "intellectual capital" in medical technology reflects the high valuation of their patented technology.
%20of%20the%20company%20Biosig%20Technologies%20(BSGM)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Biosig-Technologies-BSGM&v=1772630150785 "Chart of market capitalization per employee (in thousands of dollars) of the company Biosig Technologies (BSGM)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Biosig Technologies is developing an innovative system for cardiologists that helps improve cardiac signal reading during procedures. The company's value lies in its patented technology. This chart shows the market premium placed on medical innovations that can improve the precision and safety of complex procedures.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772630150801 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
BioSig Technologies develops and commercializes technology to minimize noise and artifacts in electrocardiograms. It is an innovative medical device company. The high employee rating reflects the value of its patented technology, which has the potential to become a new standard in electrophysiology, improving the diagnosis of cardiac arrhythmias.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772630150818 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Biosig Technologies (BSGM)
Biosig Technologies is developing an advanced system (PURE EP) for reading cardiac signals during arrhythmia treatment procedures (ablation). This is niche medical technology R&D. This chart shows how much the company spends (negative profit) on each engineer and salesperson in an attempt to commercialize this complex diagnostic technology.
%20Chart%20Biosig%20Technologies%20(BSGM)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Biosig-Technologies-BSGM&v=1772630150875 "Company Profit Per Employee (in thousands of dollars) Chart Biosig Technologies (BSGM)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Biosig Technologies is developing and commercializing an innovative technology for reducing noise in electrocardiograms used in the treatment of arrhythmia. This graph shows the company's success in implementing its technology. Growth will depend on the increasing number of hospitals purchasing and using their PURE EP system.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772630150942 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Biosig Technologies (BSGM) is a company that has developed an innovative system (PURE EP) for more accurate cardiac signal acquisition during arrhythmia treatment procedures. It is a MedTech company. This indicator is likely low or negative, as the company is incurring R&D costs and attempting to commercialize its technology.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772630151007 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Biosig Technologies (BSGM)
BioSig Technologies is developing a technology to reduce noise in electrocardiograms used in cardiology. This chart shows how the company is commercializing its innovative system. Increasing revenue per employee will indicate adoption of their technology by leading clinics.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Biosig-Technologies-BSGM&v=1772630151041 "Sales chart per company employee Biosig Technologies (BSGM)")
Sales per employee in the market segment - Therapeutic medical equipment
Biosig Technologies developed the PURE EP system, which helps electrophysiologists obtain clearer cardiac signals during surgeries (for example, when treating arrhythmia). They are R&D and medical equipment companies. This graph shows their current stage of commercialization. Their team's productivity lies in their ability to sell this system to hospitals.
Sales per employee for the market as a whole
Hudson Pacific Properties (HPP) is a REIT that owns a portfolio of high-end office buildings and studios (for film production), primarily on the West Coast, focused on the technology and media sectors. Like most REITs, HPP has a small team. This chart shows how effectively this team manages its unique portfolio, generating rental income from both offices and soundstages.
Short shares by company, segment and market as a whole
Shares shorted by company Biosig Technologies (BSGM)
Biosig (BSGM) is developing technology to improve ECG signal quality during heart surgery. This chart shows the number of short positions. Bears doubt the technology will be widely adopted by hospitals, and the company remains unprofitable.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Biosig-Technologies-BSGM&v=1772630151196 "Short Shares Chart for the Company Biosig Technologies (BSGM)")
Shares shorted by market segment - Therapeutic medical equipment
Biosig (BSGM) has developed a system (PURE EP) for more accurate visualization of cardiac signals during arrhythmia treatment. The chart below shows the overall short position in the medical equipment sector. It illustrates how skeptical investors are about the speed of adoption of new technologies in hospitals or fear competition.
Shares shorted by the overall market
Biosig Technologies is developing an innovative cardiology system (ECG signal enhancement). This chart illustrates the overall market pessimism. Investors fear that during the crisis, hospitals will freeze budgets for new, "non-critical" equipment, and the commercialization of BSGM's product will stall.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Biosig Technologies (BSGM)
Biosig Technologies (BSGM) has developed the cutting-edge PURE EP system for obtaining clear cardiac signals during arrhythmia treatment procedures. It's a highly specialized medical technology. This chart measures the rate of price change. It helps identify when stocks are "overheated" (above 70) due to selling news or "oversold" (below 30) due to slow adoption.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Biosig-Technologies-BSGM&v=1772630151237 "RSI 14 indicator chart for the company's stock Biosig Technologies (BSGM)")
RSI 14 Market Segment - Therapeutic medical equipment
Biosig Technologies has developed the innovative PURE EP™ system for cardiology. This technology helps electrophysiologists obtain clearer signals from the heart during arrhythmia ablation procedures. This indicator reflects the overall momentum in the therapeutic medical equipment sector and helps determine whether the entire segment is overheated by expectations.
RSI 14 for the overall market
For Biosig Technologies, a biotech company in R&D, this chart is a lifeline showing capital availability. During moments of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is shut off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BSGM (Biosig Technologies)
Biosig Technologies is the developer of the PURE EP system. This technology, used in cardiac surgery (arrhythmia treatment), removes noise from ECG signals. This chart shows the analysts' average 12-month forecast, reflecting their view of how quickly hospitals will adopt this niche but important technology.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BSGM-Biosig-Technologies&v=1772630151290 "A chart showing analyst consensus forecasts for the expected stock price. BSGM (Biosig Technologies)")
The difference between the consensus estimate and the actual stock price BSGM (Biosig Technologies)
Biosig (BSGM) is an "HD TV" for cardiologists. Their PURE EP system cleans and amplifies cardiac signals, helping surgeons perform more precise arrhythmia (AF) ablation. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe this "high-fidelity" technology will be implemented in cardiology centers.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BSGM-Biosig-Technologies&v=1772630151321 "A chart showing the difference between the consensus forecast and the actual stock price. BSGM (Biosig Technologies)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Biosig (BSGM) is a medical device company that developed PURE EP, an ECG signal "cleaning" system that assists cardiac surgeons during ablation (arrhythmia treatment). This chart shows general expectations for the therapeutic medical equipment sector. It reflects whether experts believe there is demand for "assistive" technologies in surgery.
Analysts' consensus forecast for the overall market share price
Biosig Technologies (BSGM) is a cardiac surgeon's "HD TV." Their PURE EP system "cleans" noise and provides doctors with a crystal-clear signal from the heart during complex procedures (arrhythmia). This chart shows the overall risk appetite. It reflects how much investors believe conservative hospitals are willing to spend (CapEx) on implementing new technologies.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Biosig Technologies
Biosig is a cardiac noise suppressor. Their signature feature (PURE EP) isn't the blade itself, but an auxiliary system that filters and cleans noisy electrical signals (ECG) during ablation surgery (arrhythmia treatment). This graph summarizes their implementation history. It reflects their (very slow) path to commercialization and their battle for survival.
AKIMA Market Segment Index - Therapeutic medical equipment
Biosig Technologies developed PURE EP technology. This system cleans cardiac signals (ECG) during complex cardiac surgeries (ablation), giving surgeons a clearer picture. This graph compares their composite index to the sector, showing how their cardiac technology outperforms the competition.
The AKIM Index for the overall market
BioSig Technologies is a medtech company that developed the PURE EP system for improving cardiac signal recording during ablation. This chart, which reflects the market average, is a backdrop. It helps assess how BSGM, a signal processing technology, compares to overall macroeconomic trends.
